1 Allogene Therapeutics Inc Receivables Turnover Ratio (ALLO), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Allogene Therapeutics Inc   (NASDAQ: ALLO)
 

Allogene Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Allogene Therapeutics Inc Balance Sheet, in the second quarter 2026, company has not reported any Accounts receivable.
See Allogene Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector Allogene Therapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Allogene Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALLO Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 567.5 % 166.67 % - - -
Receivable Turnover Ratio (TTM) - - - - -
ALLO's Total Ranking # # # # #
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change 567.5 % - - -12.5 % 166.67 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





ALLO Company Profile • Back to ALLO Efficiency Comparisons • Compare ALLO Receivables Turnover Ratio to its Competitors

Financial Statements
Allogene Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit ALLO's Balance sheet
Allogene Therapeutics Inc 's Sales TTM $ 7 Millions Visit ALLO's Income Statement
Sources of ALLO's Revenues Visit ALLO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALLO's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALLO's Growth Rates ALLO's Roa ALLO's Inventory Turnover Ratio ALLO's Dividend Comparisons
ALLO's Profitability Ratios ALLO's Roi ALLO's Asset Turnover Ratio ALLO's Dividend Growth
ALLO's Valuation Ratios ALLO's Roe ALLO's Financial Strength Ratios ALLO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026

Date modified: 2026-09-03T23:31:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.